Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiAlustaalates 449 $
Tunnus
Palpitations
A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.
Kokkuvõte
- Teised nimetused
- Missed heart beat, Skipped heart beat, Heart palpitations
- Kehasüsteem
- Abnormality of the cardiovascular system
PalpitationsHP:0001962
Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiAlustaalates 449 $
Read the genes linked to Palpitations, and the rest of your genome, with one test.
Alates 449 $Tasuta kohaletoimetamine · Tulemused 6–8 nädala pärast
Telli oma Genome Test107 geeni on seotud tunnusega Palpitations
Nende geenide muutused põhjustavad haruldasi haigusi, mille puhul esineb Palpitations. Enamikul selle tunnusega inimestest ei ole ühtegi neist haigustest. Selles loendis olev geen ei ütle midagi kellegi enda genoomi kohta.
| Geen | Kui sageli seda täheldatakse | Haigused |
|---|---|---|
| CAV3caveolin 3 | Alati | Esineb 2 haiguses |
| CDH2cadherin 2 | Alati | Esineb 1 haiguses |
| DTNAdystrobrevin alpha | Alati | Esineb 1 haiguses |
| EMDemerin | Alati | Esineb 2 haiguses |
| GCGRglucagon receptor | Alati | Esineb 1 haiguses |
| KCND3potassium voltage-gated channel subfamily D member 3 | Alati | Esineb 1 haiguses |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Alati | Esineb 3 haiguses |
| MYZAPmyocardial zonula adherens protein | Alati | Esineb 1 haiguses |
| POPDC2popeye domain cAMP effector 2 | Alati | Esineb 1 haiguses |
| TECRLtrans-2,3-enoyl-CoA reductase like | Alati | Esineb 1 haiguses |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Väga sageli (80–99%) | Esineb 2 haiguses |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Väga sageli (80–99%) | Esineb 1 haiguses |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Väga sageli (80–99%) | Esineb 2 haiguses |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Väga sageli (80–99%) | Esineb 2 haiguses |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Väga sageli (80–99%) | Esineb 1 haiguses |
| LAMP2lysosome associated membrane protein 2 | Väga sageli (80–99%) | Esineb 1 haiguses |
| MEN1menin 1 | Väga sageli (80–99%) | Esineb 1 haiguses |
| NPPAnatriuretic peptide A | Väga sageli (80–99%) | Esineb 3 haiguses |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Väga sageli (80–99%) | Esineb 3 haiguses |
| YY1YY1 transcription factor | Väga sageli (80–99%) | Esineb 1 haiguses |
| ABCC8ATP binding cassette subfamily C member 8 | Sageli (30–79%) | Esineb 1 haiguses |
| ABCC9ATP binding cassette subfamily C member 9 | Sageli (30–79%) | Esineb 1 haiguses |
| ACTC1actin alpha cardiac muscle 1 | Sageli (30–79%) | Esineb 2 haiguses |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Sageli (30–79%) | Esineb 1 haiguses |
| CDH23cadherin related 23 | Sageli (30–79%) | Esineb 1 haiguses |
| CDKN2Acyclin dependent kinase inhibitor 2A | Sageli (30–79%) | Esineb 1 haiguses |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Sageli (30–79%) | Esineb 2 haiguses |
| CTNNB1catenin beta 1 | Sageli (30–79%) | Esineb 1 haiguses |
| DLSTdihydrolipoamide S-succinyltransferase | Sageli (30–79%) | Esineb 1 haiguses |
| DNMT3ADNA methyltransferase 3 alpha | Sageli (30–79%) | Esineb 1 haiguses |
| DSC2desmocollin 2 | Sageli (30–79%) | Esineb 1 haiguses |
| DSG2desmoglein 2 | Sageli (30–79%) | Esineb 1 haiguses |
| EPAS1endothelial PAS domain protein 1 | Sageli (30–79%) | Esineb 1 haiguses |
| FHfumarate hydratase | Sageli (30–79%) | Esineb 1 haiguses |
| GATA4GATA binding protein 4 | Sageli (30–79%) | Esineb 2 haiguses |
| GATA5GATA binding protein 5 | Sageli (30–79%) | Esineb 1 haiguses |
| GATA6GATA binding protein 6 | Sageli (30–79%) | Esineb 2 haiguses |
| GJA5gap junction protein alpha 5 | Sageli (30–79%) | Esineb 1 haiguses |
| GYG1glycogenin 1 | Sageli (30–79%) | Esineb 1 haiguses |
| HNF1AHNF1 homeobox A | Sageli (30–79%) | Esineb 1 haiguses |
Näita veel 67 geeni
| Geen | Kui sageli seda täheldatakse | Haigused |
|---|---|---|
| JPH2junctophilin 2 | Sageli (30–79%) | Esineb 1 haiguses |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Sageli (30–79%) | Esineb 1 haiguses |
| KCNH2potassium voltage-gated channel subfamily H member 2 | Sageli (30–79%) | Esineb 2 haiguses |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Sageli (30–79%) | Esineb 1 haiguses |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Sageli (30–79%) | Esineb 6 haiguses |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Sageli (30–79%) | Esineb 1 haiguses |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Sageli (30–79%) | Esineb 2 haiguses |
| KIF1Bkinesin family member 1B | Sageli (30–79%) | Esineb 1 haiguses |
| KLHL24kelch like family member 24 | Sageli (30–79%) | Esineb 1 haiguses |
| MAXMYC associated transcriptional regulator X | Sageli (30–79%) | Esineb 1 haiguses |
| MDH2malate dehydrogenase 2 | Sageli (30–79%) | Esineb 1 haiguses |
| MYH6myosin heavy chain 6 | Sageli (30–79%) | Esineb 1 haiguses |
| MYH7myosin heavy chain 7 | Sageli (30–79%) | Esineb 1 haiguses |
| MYL4myosin light chain 4 | Sageli (30–79%) | Esineb 2 haiguses |
| MYOZ2myozenin 2 | Sageli (30–79%) | Esineb 1 haiguses |
| NF1neurofibromin 1 | Sageli (30–79%) | Esineb 1 haiguses |
| NKX2-5NK2 homeobox 5 | Sageli (30–79%) | Esineb 2 haiguses |
| NKX2-6NK2 homeobox 6 | Sageli (30–79%) | Esineb 1 haiguses |
| NUP155nucleoporin 155 | Sageli (30–79%) | Esineb 1 haiguses |
| PITX2paired like homeodomain 2 | Sageli (30–79%) | Esineb 1 haiguses |
| PKP2plakophilin 2 | Sageli (30–79%) | Esineb 1 haiguses |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Sageli (30–79%) | Esineb 1 haiguses |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Sageli (30–79%) | Esineb 1 haiguses |
| RETret proto-oncogene | Sageli (30–79%) | Esineb 3 haiguses |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Sageli (30–79%) | Esineb 1 haiguses |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Sageli (30–79%) | Esineb 1 haiguses |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Sageli (30–79%) | Esineb 1 haiguses |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Sageli (30–79%) | Esineb 1 haiguses |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Sageli (30–79%) | Esineb 1 haiguses |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Sageli (30–79%) | Esineb 1 haiguses |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Sageli (30–79%) | Esineb 3 haiguses |
| SDHCsuccinate dehydrogenase complex subunit C | Sageli (30–79%) | Esineb 2 haiguses |
| SDHDsuccinate dehydrogenase complex subunit D | Sageli (30–79%) | Esineb 4 haiguses |
| SLC25A11solute carrier family 25 member 11 | Sageli (30–79%) | Esineb 1 haiguses |
| SLC4A3solute carrier family 4 member 3 | Sageli (30–79%) | Esineb 1 haiguses |
| TBX20T-box transcription factor 20 | Sageli (30–79%) | Esineb 1 haiguses |
| TERTtelomerase reverse transcriptase | Sageli (30–79%) | Esineb 1 haiguses |
| TLL1tolloid like 1 | Sageli (30–79%) | Esineb 2 haiguses |
| TMEM126Btransmembrane protein 126B | Sageli (30–79%) | Esineb 1 haiguses |
| TMEM127transmembrane protein 127 | Sageli (30–79%) | Esineb 1 haiguses |
| TP53tumor protein p53 | Sageli (30–79%) | Esineb 1 haiguses |
| TTNtitin | Sageli (30–79%) | Esineb 1 haiguses |
| UCP2uncoupling protein 2 | Sageli (30–79%) | Esineb 1 haiguses |
| VHLvon Hippel-Lindau tumor suppressor | Sageli (30–79%) | Esineb 3 haiguses |
| ZNRF3zinc and ring finger 3 | Sageli (30–79%) | Esineb 1 haiguses |
| ADAMTS19ADAM metallopeptidase with thrombospondin type 1 motif 19 | Mõnikord (5–29%) | Esineb 1 haiguses |
| BAG3BAG cochaperone 3 | Mõnikord (5–29%) | Esineb 1 haiguses |
| CCND1cyclin D1 | Mõnikord (5–29%) | Esineb 1 haiguses |
| JUPjunction plakoglobin | Mõnikord (5–29%) | Esineb 1 haiguses |
| THRBthyroid hormone receptor beta | Mõnikord (5–29%) | Esineb 1 haiguses |
| TRIM63tripartite motif containing 63 | Mõnikord (5–29%) | Esineb 1 haiguses |
| ATRXATRX chromatin remodeler | Harva (1–4%) | Esineb 1 haiguses |
| CLCNKBchloride voltage-gated channel Kb | Harva (1–4%) | Esineb 1 haiguses |
| POLGDNA polymerase gamma, catalytic subunit | Harva (1–4%) | Esineb 1 haiguses |
| POLG2DNA polymerase gamma 2, accessory subunit | Harva (1–4%) | Esineb 1 haiguses |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Harva (1–4%) | Esineb 1 haiguses |
| SLC12A3solute carrier family 12 member 3 | Harva (1–4%) | Esineb 2 haiguses |
| SLC25A4solute carrier family 25 member 4 | Harva (1–4%) | Esineb 1 haiguses |
| TWNKtwinkle mtDNA helicase | Harva (1–4%) | Esineb 1 haiguses |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Pole registreeritud | Esineb 1 haiguses |
| ISCUiron-sulfur cluster assembly enzyme | Pole registreeritud | Esineb 1 haiguses |
| MYL2myosin light chain 2 | Pole registreeritud | Esineb 1 haiguses |
| MYL3myosin light chain 3 | Pole registreeritud | Esineb 1 haiguses |
| POPDC1popeye domain cAMP effector 1 | Pole registreeritud | Esineb 1 haiguses |
| PRKAG2protein kinase AMP-activated non-catalytic subunit gamma 2 | Pole registreeritud | Esineb 2 haiguses |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Pole registreeritud | Esineb 1 haiguses |
| TMEM43transmembrane protein 43 | Pole registreeritud | Esineb 1 haiguses |
Kui sageli see esineb geenist tulenevate seisunditega inimeste seas, kõige sagedamini nende kõigi seas, nagu on märgitud Inimese fenotüübi ontoloogias. Need lehed kirjeldavad tunnuseid ja nende taga olevaid uuringuid; need ei ole diagnoos ning sümptomite kohta tuleks küsida arstilt või geneetilt nõustajalt.
Laiemad tunnused
Allikas
- Inimese fenotüübi ontoloogia, versioon 2026-09-01: tunnus, selle nimetused, määratlus ja sellega seotud geenid. Lisateave leiab aadressilt hpo.jax.org.
- Andmeversioon 2026.10.16-c6eea6bf.
Kellele me abiks olemeMeie teadusTootedTulemused
Logi sisseKüsiAlustaalates 449 $
Üks test. Vastused kogu eluks.
Alates 449 $Tasuta kohaletoimetamine · Tulemused 6–8 nädala pärast